President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

Also in this newsletter, the weight-loss drug Mounjaro makes its India debut and stock markets on ‘liberation day’ ...

The agency had previously drawn up plans to cut roughly 18% to 20% of the 100,000-person workforce by the middle of May.

The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.

President Donald Trump is expected to announce sweeping tariffs on “all countries” intended to re-balance global trade and ...

President Donald Trump used a simple trick to enjoy his ... There was speculation he had taken weight-loss drugs such as Ozempic or Wegovy. Trump finally addressed his dramatic physical change.

The market weighed some weak economic data and awaited clarity from President Donald Trump regarding his tariff policy ...